ShareValue scores for GAUDIUMIVF.NSE: Valuation 39, Quality 47, Growth 50, Health 51.

GAUDIUMIVF.NSE
NSE

GAUDIUMIVF

₹111.41(-2.00%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

-6% to 10%
Valuation
39
Overvalued
Price vs Value
Quality
47
Moderate
Business Strength
Growth
50
Moderate
Revenue & Earnings
Health
51
Moderate
Financial Stability
Momentum
69
Bullish
Price Trend

Company Details

About

Gaudium IVF and Women Health Limited provides in vitro fertilization (IVF) treatment in India. The company offers fertility and reproductive health services, including intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), and ovulation induction; polycystic ovarian syndrome (PCOS)/ polycystic ovarian disease (PCOD); endometriosis treatment; ovulation induction; and laser assisted embryo implantation services. It also provides male infertility treatment services; infertility surgeries; egg freezing; surrogacy; and laparoscopic and hysteroscopic surgeries for the diagnosis and treatment of infertility-related conditions, as well as offers genetic testing options, including preimplantation genetic testing (PGT); and IVF consultancy services. In addition, the company operates hospital, in-house pharmacy; and 7 hubs (IVF centers) and 28 spokes. The company was founded in 2009 and is based in headquartered in New Delhi, India. Address:

Score Analysis

AI Investment Thesis

Data as of:Aug 25, 2026
|
Last calculated:Aug 25, 2026